Clinical Trial

Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers

Name: Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers — clinical trial record (NCT07438886)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a non-randomized, open-label, fixed-sequence drug-drug interaction study to evaluate the effects of itraconazole and ticagrelor on the pharmacokinetics of catequentinib hydrochloride (AL3818) in healthy volunteers.

Trial Details

NCT Number	NCT07438886
Lead Sponsor	Advenchen Laboratories Nanjing Ltd.
Conditions	Healthy Volunteer
Enrollment	16 participants
Start Date	2026-03-02
Primary Completion	2027-03-31 (estimated)
Study Completion	2027-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-27